Investors locked in profits on KaloBios Pharmaceuticals Inc. (Nasdaq: KBIO). The stock price plummeted $21.10 to close at $18.40.
Profit taking sinks KaloBios
November 24, 2015 at 17:56 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.